Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001715 · ClinicalTrials.gov registry record
Evaluation of Patients With Blood Disorders
A clinical trial of Hematologic Disease, sponsored by National Institutes of Health Clinical Center (CC).
- Completed
- Registry status
- 898
- Enrollment target
- 1
- Study location
NCT00001715: Completed study of Hematologic Disease, sponsored by National Institutes of Health Clinical Center (CC).
NCT00001715 is a study of Hematologic Disease that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 898 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001715, a study of Hematologic Disease, has completed, sponsored by National Institutes of Health Clinical Center (CC).
- COMPLETED
- Registry status
- 898 participants
- Enrollment target
- 1
- Study location
Study Summary
The Hematology Service provides hematology consultations for patients at the Clinical Center and participates in the training of hematology fellows. Patients with a broad range of hematologic disorders must be available in order for the senior staff of the Service to maintain clinical expertise and to provide the breadth of experience necessary for the fellowship program. The purpose of this protocol is to meet these needs by allowing the Hematology Service to see patients with a spectrum of hematologic diseases not studied on existing research protocols at the NIH. These patients will be evaluated over the course of several outpatient visits and returned to the care of their referring physicians.This study was developed to evaluate and possibly treat patients with blood disorders. The Hematology Service of the National Institutes of Health is responsible for the care of patients participating in research studies. In addition the Hematology Service also provides consultation for small groups of patients with blood disorders that have not been diagnosed or that may need special testing. This study will also provide doctors at the NIH the opportunity to learn more about a wide range of blood disorders and conditions. Patients participating in this study will be evaluated over the course of several outpatient visits and will continue to be cared for by their regular physician.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 898 participants |
| Start Date | 1998-04-21 |
| Est. Completion | 2017-08-23 |
What the finished NCT00001715 record still lists
NCT00001715 is an observational study that tracks outcomes without assigning an intervention. The registered 898 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Hematologic Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00001715 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00001715 about?
NCT00001715 is a clinical study titled "Evaluation of Patients With Blood Disorders". The Hematology Service provides hematology consultations for patients at the Clinical Center and participates in the training of hematology fellows. Patients with a broad range of hematologic disorders must be available in order for the senior staff of the Service to maintain clinical expertise and ...
What is the current status of trial NCT00001715?
This trial is currently completed. The enrollment target is 898 participants. The study started on 1998-04-21. Estimated completion is 2017-08-23.
What conditions does trial NCT00001715 study?
This clinical trial studies the following conditions: Hematologic Disease.
Who is sponsoring clinical trial NCT00001715?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001715 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hematologic Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02352116 · 900 participants · NA
Evaluation of Post-PACU Pain Management in Pediatric Surgery
- NCT02414347 · 900 participants
F 18 T807 Tau PET Imaging of Alzheimer's Disease
- NCT02670408 · 900 participants
Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
- NCT02960022 · 900 participants · Phase 2
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI